ARTV

Artiva Biotherapeutics, Inc. · XNAS

Season: Q2 2026 · as of Jun 30
Holders: 1 of 97 filed
Median weight: 0.07%
Sector: Health Care
Type: equity · US

Moves1 this quarter

+0.1 pp in · 0.0 pp out

New 1 +0.07 pp
Added 0 0.00 pp
Trimmed 0 0.00 pp
Exited 0 0.00 pp

Streakslongest holders · 1 quarters on record

Viking Andreas Halvorsen, CEO 0.1%new

The record for ARTV begins Q2 2026: 1 quarters.

Holders1 of 97 filed


VikingAndreas Halvorsen, CEO	0.07%	2,604,166	$25M	new	+0.07 pp	new